ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtable

ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtable

Abstract Background The global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causing the ongoing coronavirus disease 2019 (COVID-19) pandemic has raised serious concern for patients with chronic disease. A correlation has been identified between the severity of COV...

Full description

Bibliographic Details
Main Authors: Thomas H. Brannagan, Michaela Auer-Grumbach, John L. Berk, Chiara Briani, Vera Bril, Teresa Coelho, Thibaud Damy, Angela Dispenzieri, Brian M. Drachman, Nowell Fine, Hanna K. Gaggin, Morie Gertz, Julian D. Gillmore, Esther Gonzalez, Mazen Hanna, David R. Hurwitz, Sami L. Khella, Mathew S. Maurer, Jose Nativi-Nicolau, Kemi Olugemo, Luis F. Quintana, Andrew M. Rosen, Hartmut H. Schmidt, Jacqueline Shehata, Marcia Waddington-Cruz, Carol Whelan, Frederick L. Ruberg
Format: Article
Language:English
Published: BMC 2021-05-01
Series:Orphanet Journal of Rare Diseases
Subjects:
COVID-19
SARS-CoV-2
Amyloidosis
Rare disease
ATTR
Online Access:https://doi.org/10.1186/s13023-021-01834-0

Internet

https://doi.org/10.1186/s13023-021-01834-0

Similar Items